Fluorine18FLTQualityChecker

Fluorine-18 FLT

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity PET
Open selection

Utility description: Fluorine-18 FLT

Fluorine-18 FLT Quality Checker — Fluorine-18 FLT for PET Proliferation Imaging

ℹ️  Utility checks critical parameters of [18F]FLT (3'-deoxy-3'-[18F]fluorothymidine):
    • Radionuclidic purity (≥99.9%)
    • Radiochemical purity (≥95%)
    • Free Fluoride-18 impurity (≤5.0%)
    • Precursor/Cold FLT impurity (≤2.0%)
    • Specific activity (≥50 GBq/μmol)
    • Residual solvents (ethanol), pH, endotoxins, sterility

⚠️  CRITICAL: Free Fluoride-18 >5.0% → accumulation in bones, risk of false positives in bone metastasis detection!

Usage:
  Fluorine18FLTQualityChecker.exe                            → demo mode (console output)
  Fluorine18FLTQualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,RadionuclidicPurityPercent,RadiochemicalPurityPercent,FreeFluoridePercent,PrecursorImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ResidualEthanolPercent,SpecificActivityGBqPerUmol

Example (sterility: 0=sterile, 1=contaminated):
  F18-FLT-2026-001,99.99,98.0,1.5,0.5,7.0,30.0,0,2,5.0,120.0

— WHY IS THIS NEEDED?
[18F]FLT is used for Positron Emission Tomography (PET) to assess cellular proliferation:
• Mechanism: FLT is a substrate for Thymidine Kinase 1 (TK1), activity of which correlates with DNA synthesis phase and cell division
• Main application: Oncology (assessment of tumor aggressiveness, early response to chemo- or radiotherapy)
• Advantage over FDG: More specific for proliferation, less dependent on inflammation

⚠️  CRITICAL:
• Radiochemical purity ≥95% — ensures specific phosphorylation by TK1 enzyme inside cells
• Free Fluoride ≤5.0% — [18F]fluoride is actively taken up by bone tissue. When assessing proliferation in bone marrow or bone metastases, this creates critical background
• Specific activity ≥50 GBq/μmol — necessary to minimize competitive inhibition of TK1 enzyme by cold thymidine/FLT
• Residual Solvents (Ethanol) — controlled per ICH Q3C
• pH 4.5–8.5 — physiological range
• Endotoxins ≤175 EU/vial — safety standard
• Sterility — MANDATORY

Key features:
• Specific control of free fluoride due to risk of bone artifacts
• Specific activity control to ensure sensitivity to TK1 expression levels
• Residual solvent check

Critical parameters:
• Radionuclidic purity: ≥99.9%
• Radiochemical purity: ≥95.0%
• Free Fluoride-18: ≤5.0%
• Precursor/Cold drug: ≤2.0%
• Specific activity: ≥50.0 GBq/μmol
• Ethanol: ≤10.0%
• pH: 4.5–8.5
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm

💡 Usage tips:
1. Radiochemical purity and free fluoride content determined by TLC or HPLC
2. For TLC, systems such as acetonitrile/water are often used
3. Specific activity calculated from activity to molar amount ratio (HPLC-UV)
4. FLT has lower uptake in the brain compared to FDG, making it useful for assessing brain tumors

⚠️ Note: Unlike FDG, which reflects glucose metabolism, FLT is directly linked to DNA synthesis. Therefore, quality control must ensure the absence of impurities that could inhibit or compete for enzymes in the thymidine salvage pathway.

input.csv

BatchNumber,RadionuclidicPurityPercent,RadiochemicalPurityPercent,FreeFluoridePercent,PrecursorImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ResidualEthanolPercent,SpecificActivityGBqPerUmol
F18-FLT-2026-001,99.99,98.0,1.5,0.5,7.0,30.0,0,2,5.0,120.0
F18-FLT-2026-002,99.95,94.0,6.5,1.0,6.8,100.0,0,5,8.0,40.0
F18-FLT-2026-003,99.98,99.0,0.5,0.2,7.2,10.0,0,1,2.0,200.0

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Fluorine18FLTQualityChecker for Fluorine-18 FLT.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of [18F]FLT (3'-deoxy-3'-[18F]fluorothymidine):
  • • Radionuclidic purity (≥99.9%)
  • • Radiochemical purity (≥95%)
  • • Free Fluoride-18 impurity (≤5.0%)
  • • Precursor/Cold FLT impurity (≤2.0%)
  • • Specific activity (≥50 GBq/μmol)
  • • Residual solvents (ethanol), pH, endotoxins, sterility
  • ⚠️ CRITICAL: Free Fluoride-18 >5.0% → accumulation in bones, risk of false positives in bone metastasis detection!
  • BatchNumber,RadionuclidicPurityPercent,RadiochemicalPurityPercent,FreeFluoridePercent,PrecursorImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ResidualEthanolPercent,SpecificActivityGBqPerUmol
  • Example (sterility: 0=sterile, 1=contaminated):
  • ⚠️ CRITICAL:
  • • Radiochemical purity ≥95% — ensures specific phosphorylation by TK1 enzyme inside cells
  • • Free Fluoride ≤5.0% — [18F]fluoride is actively taken up by bone tissue. When assessing proliferation in bone marrow or bone metastases, this creates critical background
  • • Specific activity ≥50 GBq/μmol — necessary to minimize competitive inhibition of TK1 enzyme by cold thymidine/FLT

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Fluorine-18 FLT using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringF18-FLT-2026-001Batch or lot identifier used for traceability.
2RadionuclidicPurityPercentstring99.99Radionuclidic purity; a critical radiation-safety and impurity parameter.
3RadiochemicalPurityPercentstring98.0Radiochemical purity; confirms the labelled chemical form and binding quality.
4FreeFluoridePercentstring1.5Free radionuclide / unbound species; important for non-target uptake and toxicity.
5PrecursorImpurityPercentstring0.5Controlled impurity or residual material.
6pHdecimal7.0Solution pH; relevant for stability, compatibility and administration.
7EndotoxinsEUdecimal30.0Bacterial endotoxins; critical for parenteral administration.
8SterilityTestflag / boolean0Sterility result; critical release parameter.
9HeavyMetalsPPMdecimal2Elemental impurity / metal residue parameter.
10ResidualEthanolPercentstring5.0Controlled input parameter used by the deterministic QC rules.
11SpecificActivityGBqPerUmoldecimal120.0Radioactivity value used for release, decay or dose-related assessment.
BatchNumber,RadionuclidicPurityPercent,RadiochemicalPurityPercent,FreeFluoridePercent,PrecursorImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ResidualEthanolPercent,SpecificActivityGBqPerUmol
F18-FLT-2026-001,99.99,98.0,1.5,0.5,7.0,30.0,0,2,5.0,120.0
F18-FLT-2026-002,99.95,94.0,6.5,1.0,6.8,100.0,0,5,8.0,40.0
F18-FLT-2026-003,99.98,99.0,0.5,0.2,7.2,10.0,0,1,2.0,200.0

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Fluorine-18 FLT, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "fluorine18-flt-quality-checker",
  "api": "Fluorine-18 FLT",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "F18-FLT-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadionuclidicPurityPercent",
      "value": "99.99",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "98.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "FreeFluoridePercent",
      "value": "1.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "PrecursorImpurityPercent",
      "value": "0.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH",
      "value": "7.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "EndotoxinsEU",
      "value": "30.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "SterilityTest",
      "value": "0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

Diabetes QC Suite

QC package for diabetes medicines: insulins, metformin, SGLT2/DPP-4/GLP-1 products, glucagon and supporting dosage-form quality checks.

Open

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH isotope family: short-lived PET isotopes

F-18, C-11, N-13, O-15 and related PET production, release and imaging workflows.

Open

RPH organ/system: bone and musculoskeletal

Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.

Open

RPH organ/system: brain and CNS

Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.

Open

RPH organ/system: lymphatic, infection and inflammation

Sentinel node, lymphoscintigraphy, nanocolloid, labelled leukocytes, granulocyte and inflammatory imaging.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH use case: PET/SPECT oncology diagnostics and receptor imaging

F-18, Ga-68, Cu-64, Zr-89, In-111 and other diagnostic tracers: synthesis, purity, receptor targeting, immuno-PET and generator-based workflows.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: synthesis, labelling and kit reconstitution

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open